6 results match your criteria: "Centre de Référence des Maladies Auto-Inflammatoires et des Amyloses Inflammatoires (CEREMAIA)[Affiliation]"
Extra-osseous manifestations in chronic recurrent multifocal osteomyelitis: a retrospective study.
Rheumatology (Oxford)
September 2024
Service de Rhumatologie Pédiatrique, Centre de Référence des Maladies Auto-Inflammatoires et des Amyloses Inflammatoires (CEREMAIA), Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris (AP-HP), Le Kremlin-Bicêtre, France.
Objectives: Extra-osseous (EO) manifestations are poorly characterized in chronic recurrent multifocal osteomyelitis (CRMO). This study aimed to further define the frequency, characteristics and treatment of EO events in CRMO and whether different phenotypes can be distinguished and benefit from special management.
Methods: This multicentre retrospective study included CRMO patients followed in several paediatric rheumatology departments in France between 2015 and 2022.
Quality of life assessment by SF-36 in elderly patients with familial Mediterranean fever: a comparative cross-sectional study from the Juvenile Inflammatory Rheumatism cohort.
Clin Exp Rheumatol
September 2022
Sorbonne Université, GRAASU GRC, Service de Médecine Interne, Centre de Référence des Maladies Auto-Inflammatoires et des Amyloses Inflammatoires (CEREMAIA), Hôpital Tenon, AP-HP, Paris, France.
Specific changes in faecal microbiota are associated with familial Mediterranean fever.
Ann Rheum Dis
October 2019
Service de Médecine Interne, Centre de référence des maladies auto-inflammatoires et des amyloses inflammatoires (CEREMAIA), Sorbonne Université, Assistance Publique des Hôpitaux de Paris, Hôpital Tenon, Paris, France
Objectives: Familial Mediterranean fever (FMF) can be complicated by AA amyloidosis (AAA), though it remains unclear why only some patients develop amyloidosis. We examined the gut microbiota composition and inflammatory markers in patients with FMF complicated or not by AAA.
Methods: We analysed the gut microbiota of 34 patients with FMF without AAA, 7 patients with FMF with AAA, 19 patients with AAA of another origin, and 26 controls using 16S ribosomal RNA gene sequencing with the Illumina MiSeq platform.
[Validation of the usual values provided by a supplier without access to a control population: example of serum amyloid A].
Ann Biol Clin (Paris)
June 2019
UF biomarqueurs inflammatoires et métaboliques, Service de biochimie et hormonologie, Hôpital Tenon, AP-HP, Paris, France, Sorbonne Université, Inserm UMRS_938, CDR-Saint-Antoine, DHU i2B, IHU ICAN, Paris, France.
Unlabelled: As part of the laboratory accreditation process, it may be required to determine the laboratory's own reference values. Thus, we have accredited in our laboratory, the serum amyloid A (SAA) assay for which the supplier gave the usual values. However, we did not have a reference population to check them.
View Article and Find Full Text PDFCommentary to "A 44-year-old female with familial Mediterranean fever, cardiomyopathy and end stage renal disease" by Magaki et al.
Brain Pathol
March 2019
Department of Pathology, Sorbonne Université, AP-HP, Tenon Hospital, Paris, France.
Rheumatoid arthritis revealed by polyadenopathy, diarrhea and digestive AA amyloidosis.
Joint Bone Spine
May 2019
Department of internal medicine, Tenon hospital, centre de référence des maladies auto-inflammatoires et des amyloses inflammatoires (CEREMAIA), 4, rue de la Chine, 75020 Paris, France; Paris VI university, 75005 Paris, France. Electronic address: